Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilars Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Insulin
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biosimilars Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimilars Drug Market Perspective (2018-2029)
2.2 Biosimilars Drug Growth Trends by Region
2.2.1 Global Biosimilars Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biosimilars Drug Historic Market Size by Region (2018-2024)
2.2.3 Biosimilars Drug Forecasted Market Size by Region (2024-2029)
2.3 Biosimilars Drug Market Dynamics
2.3.1 Biosimilars Drug Industry Trends
2.3.2 Biosimilars Drug Market Drivers
2.3.3 Biosimilars Drug Market Challenges
2.3.4 Biosimilars Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilars Drug Players by Revenue
3.1.1 Global Top Biosimilars Drug Players by Revenue (2018-2024)
3.1.2 Global Biosimilars Drug Revenue Market Share by Players (2018-2024)
3.2 Global Biosimilars Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosimilars Drug Revenue
3.4 Global Biosimilars Drug Market Concentration Ratio
3.4.1 Global Biosimilars Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilars Drug Revenue in 2022
3.5 Biosimilars Drug Key Players Head office and Area Served
3.6 Key Players Biosimilars Drug Product Solution and Service
3.7 Date of Enter into Biosimilars Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilars Drug Breakdown Data by Type
4.1 Global Biosimilars Drug Historic Market Size by Type (2018-2024)
4.2 Global Biosimilars Drug Forecasted Market Size by Type (2024-2029)
5 Biosimilars Drug Breakdown Data by Application
5.1 Global Biosimilars Drug Historic Market Size by Application (2018-2024)
5.2 Global Biosimilars Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biosimilars Drug Market Size (2018-2029)
6.2 North America Biosimilars Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biosimilars Drug Market Size by Country (2018-2024)
6.4 North America Biosimilars Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosimilars Drug Market Size (2018-2029)
7.2 Europe Biosimilars Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biosimilars Drug Market Size by Country (2018-2024)
7.4 Europe Biosimilars Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilars Drug Market Size (2018-2029)
8.2 Asia-Pacific Biosimilars Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biosimilars Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Biosimilars Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosimilars Drug Market Size (2018-2029)
9.2 Latin America Biosimilars Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biosimilars Drug Market Size by Country (2018-2024)
9.4 Latin America Biosimilars Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilars Drug Market Size (2018-2029)
10.2 Middle East & Africa Biosimilars Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biosimilars Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Biosimilars Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qilu Pharmaceutical
11.1.1 Qilu Pharmaceutical Company Detail
11.1.2 Qilu Pharmaceutical Business Overview
11.1.3 Qilu Pharmaceutical Biosimilars Drug Introduction
11.1.4 Qilu Pharmaceutical Revenue in Biosimilars Drug Business (2018-2024)
11.1.5 Qilu Pharmaceutical Recent Development
11.2 Bio-Thera
11.2.1 Bio-Thera Company Detail
11.2.2 Bio-Thera Business Overview
11.2.3 Bio-Thera Biosimilars Drug Introduction
11.2.4 Bio-Thera Revenue in Biosimilars Drug Business (2018-2024)
11.2.5 Bio-Thera Recent Development
11.3 Zhejiang Hisun
11.3.1 Zhejiang Hisun Company Detail
11.3.2 Zhejiang Hisun Business Overview
11.3.3 Zhejiang Hisun Biosimilars Drug Introduction
11.3.4 Zhejiang Hisun Revenue in Biosimilars Drug Business (2018-2024)
11.3.5 Zhejiang Hisun Recent Development
11.4 Shanghai Henlius
11.4.1 Shanghai Henlius Company Detail
11.4.2 Shanghai Henlius Business Overview
11.4.3 Shanghai Henlius Biosimilars Drug Introduction
11.4.4 Shanghai Henlius Revenue in Biosimilars Drug Business (2018-2024)
11.4.5 Shanghai Henlius Recent Development
11.5 Innovent Biologics
11.5.1 Innovent Biologics Company Detail
11.5.2 Innovent Biologics Business Overview
11.5.3 Innovent Biologics Biosimilars Drug Introduction
11.5.4 Innovent Biologics Revenue in Biosimilars Drug Business (2018-2024)
11.5.5 Innovent Biologics Recent Development
11.6 Jiangsu Hengrui
11.6.1 Jiangsu Hengrui Company Detail
11.6.2 Jiangsu Hengrui Business Overview
11.6.3 Jiangsu Hengrui Biosimilars Drug Introduction
11.6.4 Jiangsu Hengrui Revenue in Biosimilars Drug Business (2018-2024)
11.6.5 Jiangsu Hengrui Recent Development
11.7 Gan&Lee
11.7.1 Gan&Lee Company Detail
11.7.2 Gan&Lee Business Overview
11.7.3 Gan&Lee Biosimilars Drug Introduction
11.7.4 Gan&Lee Revenue in Biosimilars Drug Business (2018-2024)
11.7.5 Gan&Lee Recent Development
11.8 Tonghua Dongbao
11.8.1 Tonghua Dongbao Company Detail
11.8.2 Tonghua Dongbao Business Overview
11.8.3 Tonghua Dongbao Biosimilars Drug Introduction
11.8.4 Tonghua Dongbao Revenue in Biosimilars Drug Business (2018-2024)
11.8.5 Tonghua Dongbao Recent Development
11.9 United Laboratory
11.9.1 United Laboratory Company Detail
11.9.2 United Laboratory Business Overview
11.9.3 United Laboratory Biosimilars Drug Introduction
11.9.4 United Laboratory Revenue in Biosimilars Drug Business (2018-2024)
11.9.5 United Laboratory Recent Development
11.10 3SBIO
11.10.1 3SBIO Company Detail
11.10.2 3SBIO Business Overview
11.10.3 3SBIO Biosimilars Drug Introduction
11.10.4 3SBIO Revenue in Biosimilars Drug Business (2018-2024)
11.10.5 3SBIO Recent Development
11.11 Luye Pharma
11.11.1 Luye Pharma Company Detail
11.11.2 Luye Pharma Business Overview
11.11.3 Luye Pharma Biosimilars Drug Introduction
11.11.4 Luye Pharma Revenue in Biosimilars Drug Business (2018-2024)
11.11.5 Luye Pharma Recent Development
11.12 Celltrion
11.12.1 Celltrion Company Detail
11.12.2 Celltrion Business Overview
11.12.3 Celltrion Biosimilars Drug Introduction
11.12.4 Celltrion Revenue in Biosimilars Drug Business (2018-2024)
11.12.5 Celltrion Recent Development
11.13 Pfizer
11.13.1 Pfizer Company Detail
11.13.2 Pfizer Business Overview
11.13.3 Pfizer Biosimilars Drug Introduction
11.13.4 Pfizer Revenue in Biosimilars Drug Business (2018-2024)
11.13.5 Pfizer Recent Development
11.14 Novartis
11.14.1 Novartis Company Detail
11.14.2 Novartis Business Overview
11.14.3 Novartis Biosimilars Drug Introduction
11.14.4 Novartis Revenue in Biosimilars Drug Business (2018-2024)
11.14.5 Novartis Recent Development
11.15 Dr Reddy’s
11.15.1 Dr Reddy’s Company Detail
11.15.2 Dr Reddy’s Business Overview
11.15.3 Dr Reddy’s Biosimilars Drug Introduction
11.15.4 Dr Reddy’s Revenue in Biosimilars Drug Business (2018-2024)
11.15.5 Dr Reddy’s Recent Development
11.16 Celgen Biopharma
11.16.1 Celgen Biopharma Company Detail
11.16.2 Celgen Biopharma Business Overview
11.16.3 Celgen Biopharma Biosimilars Drug Introduction
11.16.4 Celgen Biopharma Revenue in Biosimilars Drug Business (2018-2024)
11.16.5 Celgen Biopharma Recent Development
11.17 Eli Lilly
11.17.1 Eli Lilly Company Detail
11.17.2 Eli Lilly Business Overview
11.17.3 Eli Lilly Biosimilars Drug Introduction
11.17.4 Eli Lilly Revenue in Biosimilars Drug Business (2018-2024)
11.17.5 Eli Lilly Recent Development
11.18 Sanofi
11.18.1 Sanofi Company Detail
11.18.2 Sanofi Business Overview
11.18.3 Sanofi Biosimilars Drug Introduction
11.18.4 Sanofi Revenue in Biosimilars Drug Business (2018-2024)
11.18.5 Sanofi Recent Development
11.19 Geropharm
11.19.1 Geropharm Company Detail
11.19.2 Geropharm Business Overview
11.19.3 Geropharm Biosimilars Drug Introduction
11.19.4 Geropharm Revenue in Biosimilars Drug Business (2018-2024)
11.19.5 Geropharm Recent Development
11.20 Biocon
11.20.1 Biocon Company Detail
11.20.2 Biocon Business Overview
11.20.3 Biocon Biosimilars Drug Introduction
11.20.4 Biocon Revenue in Biosimilars Drug Business (2018-2024)
11.20.5 Biocon Recent Development
11.21 Wockhardt
11.21.1 Wockhardt Company Detail
11.21.2 Wockhardt Business Overview
11.21.3 Wockhardt Biosimilars Drug Introduction
11.21.4 Wockhardt Revenue in Biosimilars Drug Business (2018-2024)
11.21.5 Wockhardt Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biosimilars Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Insulin
Table 4. Key Players of Others
Table 5. Global Biosimilars Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Biosimilars Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Biosimilars Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Biosimilars Drug Market Share by Region (2018-2024)
Table 9. Global Biosimilars Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Biosimilars Drug Market Share by Region (2024-2029)
Table 11. Biosimilars Drug Market Trends
Table 12. Biosimilars Drug Market Drivers
Table 13. Biosimilars Drug Market Challenges
Table 14. Biosimilars Drug Market Restraints
Table 15. Global Biosimilars Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Biosimilars Drug Market Share by Players (2018-2024)
Table 17. Global Top Biosimilars Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars Drug as of 2022)
Table 18. Ranking of Global Top Biosimilars Drug Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Biosimilars Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biosimilars Drug Product Solution and Service
Table 22. Date of Enter into Biosimilars Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biosimilars Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Biosimilars Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Biosimilars Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Biosimilars Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Biosimilars Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Biosimilars Drug Revenue Market Share by Application (2018-2024)
Table 30. Global Biosimilars Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Biosimilars Drug Revenue Market Share by Application (2024-2029)
Table 32. North America Biosimilars Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Biosimilars Drug Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Biosimilars Drug Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Biosimilars Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Biosimilars Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Biosimilars Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Biosimilars Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Biosimilars Drug Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Biosimilars Drug Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Biosimilars Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Biosimilars Drug Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Biosimilars Drug Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Biosimilars Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Biosimilars Drug Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Biosimilars Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Qilu Pharmaceutical Company Detail
Table 48. Qilu Pharmaceutical Business Overview
Table 49. Qilu Pharmaceutical Biosimilars Drug Product
Table 50. Qilu Pharmaceutical Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 51. Qilu Pharmaceutical Recent Development
Table 52. Bio-Thera Company Detail
Table 53. Bio-Thera Business Overview
Table 54. Bio-Thera Biosimilars Drug Product
Table 55. Bio-Thera Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 56. Bio-Thera Recent Development
Table 57. Zhejiang Hisun Company Detail
Table 58. Zhejiang Hisun Business Overview
Table 59. Zhejiang Hisun Biosimilars Drug Product
Table 60. Zhejiang Hisun Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 61. Zhejiang Hisun Recent Development
Table 62. Shanghai Henlius Company Detail
Table 63. Shanghai Henlius Business Overview
Table 64. Shanghai Henlius Biosimilars Drug Product
Table 65. Shanghai Henlius Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 66. Shanghai Henlius Recent Development
Table 67. Innovent Biologics Company Detail
Table 68. Innovent Biologics Business Overview
Table 69. Innovent Biologics Biosimilars Drug Product
Table 70. Innovent Biologics Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 71. Innovent Biologics Recent Development
Table 72. Jiangsu Hengrui Company Detail
Table 73. Jiangsu Hengrui Business Overview
Table 74. Jiangsu Hengrui Biosimilars Drug Product
Table 75. Jiangsu Hengrui Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 76. Jiangsu Hengrui Recent Development
Table 77. Gan&Lee Company Detail
Table 78. Gan&Lee Business Overview
Table 79. Gan&Lee Biosimilars Drug Product
Table 80. Gan&Lee Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 81. Gan&Lee Recent Development
Table 82. Tonghua Dongbao Company Detail
Table 83. Tonghua Dongbao Business Overview
Table 84. Tonghua Dongbao Biosimilars Drug Product
Table 85. Tonghua Dongbao Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 86. Tonghua Dongbao Recent Development
Table 87. United Laboratory Company Detail
Table 88. United Laboratory Business Overview
Table 89. United Laboratory Biosimilars Drug Product
Table 90. United Laboratory Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 91. United Laboratory Recent Development
Table 92. 3SBIO Company Detail
Table 93. 3SBIO Business Overview
Table 94. 3SBIO Biosimilars Drug Product
Table 95. 3SBIO Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 96. 3SBIO Recent Development
Table 97. Luye Pharma Company Detail
Table 98. Luye Pharma Business Overview
Table 99. Luye Pharma Biosimilars Drug Product
Table 100. Luye Pharma Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 101. Luye Pharma Recent Development
Table 102. Celltrion Company Detail
Table 103. Celltrion Business Overview
Table 104. Celltrion Biosimilars Drug Product
Table 105. Celltrion Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 106. Celltrion Recent Development
Table 107. Pfizer Company Detail
Table 108. Pfizer Business Overview
Table 109. Pfizer Biosimilars Drug Product
Table 110. Pfizer Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 111. Pfizer Recent Development
Table 112. Novartis Company Detail
Table 113. Novartis Business Overview
Table 114. Novartis Biosimilars Drug Product
Table 115. Novartis Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 116. Novartis Recent Development
Table 117. Dr Reddy’s Company Detail
Table 118. Dr Reddy’s Business Overview
Table 119. Dr Reddy’s Biosimilars Drug Product
Table 120. Dr Reddy’s Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 121. Dr Reddy’s Recent Development
Table 122. Celgen Biopharma Company Detail
Table 123. Celgen Biopharma Business Overview
Table 124. Celgen Biopharma Biosimilars Drug Product
Table 125. Celgen Biopharma Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 126. Celgen Biopharma Recent Development
Table 127. Eli Lilly Company Detail
Table 128. Eli Lilly Business Overview
Table 129. Eli Lilly Biosimilars Drug Product
Table 130. Eli Lilly Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 131. Eli Lilly Recent Development
Table 132. Sanofi Company Detail
Table 133. Sanofi Business Overview
Table 134. Sanofi Biosimilars Drug Product
Table 135. Sanofi Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 136. Sanofi Recent Development
Table 137. Geropharm Company Detail
Table 138. Geropharm Business Overview
Table 139. Geropharm Biosimilars Drug Product
Table 140. Geropharm Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 141. Geropharm Recent Development
Table 142. Biocon Company Detail
Table 143. Biocon Business Overview
Table 144. Biocon Biosimilars Drug Product
Table 145. Biocon Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 146. Biocon Recent Development
Table 147. Wockhardt Company Detail
Table 148. Wockhardt Business Overview
Table 149. Wockhardt Biosimilars Drug Product
Table 150. Wockhardt Revenue in Biosimilars Drug Business (2018-2024) & (US$ Million)
Table 151. Wockhardt Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilars Drug Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Biosimilars Drug Market Share by Type: 2022 VS 2029
Figure 3. Monoclonal Antibodies Features
Figure 4. Insulin Features
Figure 5. Others Features
Figure 6. Global Biosimilars Drug Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 7. Global Biosimilars Drug Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Other Case Studies
Figure 11. Biosimilars Drug Report Years Considered
Figure 12. Global Biosimilars Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Biosimilars Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Biosimilars Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Biosimilars Drug Market Share by Players in 2022
Figure 16. Global Top Biosimilars Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Biosimilars Drug Revenue in 2022
Figure 18. North America Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Biosimilars Drug Market Share by Country (2018-2029)
Figure 20. United States Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Biosimilars Drug Market Share by Country (2018-2029)
Figure 24. Germany Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Biosimilars Drug Market Share by Region (2018-2029)
Figure 32. China Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Biosimilars Drug Market Share by Country (2018-2029)
Figure 40. Mexico Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Biosimilars Drug Market Share by Country (2018-2029)
Figure 44. Turkey Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Biosimilars Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Qilu Pharmaceutical Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 47. Bio-Thera Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 48. Zhejiang Hisun Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 49. Shanghai Henlius Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 50. Innovent Biologics Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 51. Jiangsu Hengrui Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 52. Gan&Lee Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 53. Tonghua Dongbao Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 54. United Laboratory Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 55. 3SBIO Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 56. Luye Pharma Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 57. Celltrion Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 58. Pfizer Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 59. Novartis Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 60. Dr Reddy’s Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 61. Celgen Biopharma Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 62. Eli Lilly Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 63. Sanofi Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 64. Geropharm Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 65. Biocon Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 66. Wockhardt Revenue Growth Rate in Biosimilars Drug Business (2018-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed